Double Helix, a healthcare consultancy that operates across three continents, was bought by Interpublic Group’s McCann Health, the network said Monday.
Indian conglomerate buys Manhattan Research parent for $635m
Genentech is thinking outside the traditional focus group to understand patients, helping address the long-standing business challenges of adherence and brand preference, the firm says.
Social media an outcomes listening post for pharma
FDA issues may deter drugmakers from engaging in social media, but that’s no excuse to ignore what audiences are saying on these platforms, say pharma and device firms.